Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.63M | -4.05M | 2.77M | -2.75M | -12.02M |
| Total Depreciation and Amortization | 17.00K | 17.00K | -379.00K | 153.00K | 24.00K |
| Total Amortization of Deferred Charges | -195.00K | -- | 97.00K | -- | 60.00K |
| Total Other Non-Cash Items | 6.95M | 130.00K | -6.98M | -1.51M | 7.91M |
| Change in Net Operating Assets | 1.20M | 1.49M | 809.00K | -2.34M | 1.71M |
| Cash from Operations | -2.66M | -2.41M | -3.69M | -6.44M | -2.33M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.18M | -- | -- | -- | -- |
| Cash from Investing | -5.18M | -- | 0.00 | 0.00 | -12.00K |
| Total Debt Issued | 7.30M | 250.00K | 0.00 | 200.00K | 1.66M |
| Total Debt Repaid | -767.00K | -166.00K | -111.00K | -461.00K | 0.00 |
| Issuance of Common Stock | 440.00K | 2.29M | 4.61M | 8.30M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 0.00 | -483.00K | -1.03M | -847.00K | -- |
| Total Dividends Paid | 0.00 | -90.00K | -310.00K | -347.00K | -- |
| Other Financing Activities | -- | -- | 0.00 | 100.00K | -68.00K |
| Cash from Financing | 6.97M | 1.80M | 3.16M | 6.94M | 1.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -871.00K | -606.00K | -521.00K | 497.00K | -744.00K |